Federal Register Notice: FDA is seeking public comment on the collection of information associated with the criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded in accordance with the guidance: Time and Extent Applications for Nonprescription Drug Products. Comments should be submitted by 5/23. To view this notice, click here.
